R&D 100 Award Earned by Fluxion Biosciences for IsoFlux Circulating Tumor Cell System
July 12, 2013
South San Francisco, CA Fluxion Biosciences, a leading provider of cell analysis platforms for research and diagnostics, today announced that it has won a 2013 R&D 100 Award for its IsoFlux™ System. The R&D 100 Award places the state-of-the-art IsoFlux System in the prestigious company of previous winners such as liquid crystal displays and the [...]
Thermo Fisher Scientific Declares Quarterly Dividend
July 12, 2013
WALTHAM, Mass.-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on October 15, 2013, to shareholders of record as of September 16, 2013. About Thermo Fisher Scientific Thermo Fisher [...]
July 12, 2013
GERMANTOWN, Maryland, and HILDEN, Germany, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim’s new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC [...]
METCO Environmental Introduces Rapid On-Site Analysis to their Portfolio
July 12, 2013
METCO Environmental, a TestAmerica company and a leader in source emissions testing, announced today the introduction of a portable Ion Chromatography (IC) instrument that reduces turnaround time for client results to hours from days. This IC instrument provides rapid on-site analysis for hydrogen chloride and ammonia useful for industries such as utilities, cement and combustion [...]
C2N Diagnostics Announces Collaborative Research Agreement with Cambridge Isotopes
July 12, 2013
ST. LOUIS - C2N Diagnostics (C2N) today announced that it has signed a collaborative research and a global, exclusive supplier agreement with Cambridge Isotope Laboratories, Inc (CIL). The partnership guarantees C2N’s future access to mass quantities of highly enriched stable isotopes at predictable prices. These stable isotopes are key reagents to C2N's platform of Stable [...]
Inframatic 9500 approved in Germany
July 12, 2013
The IM 9500 NIR Grain Analyzer has been officially approved by the PTB, the German authority for type approvals. The PTB has evaluated the IM 9500 during two harvests, and has concluded that it meets the requirements for official determination of moisture. With this approval, the IM 9500 can be used for moisture testing in [...]
VICAM’s New Global Mycotoxin Regulations Tool Provides Instant Access to Worldwide Regulatory Data
July 11, 2013
MILFORD, Mass. – Waters Corporation (WAT: NYSE) today announced VICAM®, a Waters® Business, introduced a single-source on-line, tool that provides access to a comprehensive, simple-to-use database of global mycotoxin regulations at commodityregs.com. Food exporters around the world face the growing challenge of ensuring that their products meet evermore demanding standards in their target markets. Varying [...]
July 11, 2013
Shimadzu Corporation released the Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals on July 10. The Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals offers quantitative, high-speed evaluation of 100 nm to 10 ?m SVP (sub-visible particle) aggregates that may be present in biopharmaceuticals. Capable of evaluating the concentration (?g/mL) of aggregates that can cause shock symptom [...]
LI-COR VRDye Secondary Antibodies for Microscopy and Flow Cytometry Now Available
July 11, 2013
Lincoln, Nebraska: LI-COR offers VRDye™ secondary antibodies and protein labeling kits for immunofluorescence microscopy and flow cytometry applications. The VRDye products broaden LI-COR’s dye product portfolio, which now spans from the visible to the near-infrared fluorescence spectrum. The new VRDye 490, VRDye 549, and IRDye® 650 secondary antibodies are highly cross-adsorbed and are suitable for [...]
Cepheid Announces Preliminary 2013 Second Quarter Results
July 11, 2013
SUNNYVALE, Calif., -- Cepheid (Nasdaq: CPHD) today announced preliminary results for the 2013 Second Quarter, ended June 30, 2013. Based on current projections, second quarter revenue is expected to be approximately $96 million, including approximately $70 million in Commercial Clinical revenue, a record $17 million from HBDC, and $9 million in Non-Clinical revenue. Within Commercial [...]

